" class="no-js "lang="en-US"> COVID-19 Archives - Page 2 of 27 - Medtech Alert
Saturday, December 09, 2023

Sort by:


Top Post

Health and Social Care Secretary Sets Out Plan for Patients With New Funding to Bolster Social Care Over Winter

‘Our plan for patients’ will inject £500 million of additional funding into adult social care […]

Omicron Infection Likely to Protect You Against Flu, Says Testing Expert

The autumn rollout of the Covid and flu vaccines will generally involve everyone eligible for both […]

Thailand Heightens Its Healthcare Hub Ambition With Integrative Medicine

Living with the COVID-19 pandemic, people start to recognize the equal importance of modern medicine and […]

Digital Rehabilitation Platform Neurofenix Completes $7 Million Series A to Transform Stroke and Brain Injury Recovery

Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in […]

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the […]

Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

£10.4m Full-service Contract Signed With Existing Big Pharma Client

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world […]

Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head

Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a multi-national company developing innovative therapies […]

Roche Launches COVID-19 Test That Detects and Differentiates the Emerging Variant of Interest BA.2.75

Roche (SIX: RO, ROG;OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed a  COVID-19 test for […]

Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-containing Bivalent Booster in the UK

Moderna, Inc . (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more